Mirabaud Asset Management has closed its Mirabaud Grand Paris strategy at €150 million. Assets were raised from large institutional and family office clients across Europe. Mirabaud Grand Paris is a unique private equity strategy investing with tier one real estate developers in France to capture opportunities from the current largest transport and urban development project in Europe: the ‘Grand Paris’ project. By combining private equity with real estate, the strategy represents a unique opportunity for investors, allowing them to provide equity financing to real estate projects directly alongside developers. It offers investors privileged access to financing projects, as well as

JB Capital, an alternative credit manager investing in areas of the market underserved by traditional banks, has launched the Real Estate Lending Income Fund. The fund, the next iteration in JB Capital’s commitment to providing credit solutions to underserved markets, will provide solutions-oriented capital to professional owners, operators and developers of multi-family and industrial real estate assets ignored and underserved by traditional funding sources in key markets across the US. The equity gap required for most investors and developers is increasing. It forces even the most successful and experienced industry professionals to look outside traditional sources of capital to close

Antwort Capital, a Luxembourg-based feeder fund platform which provides qualified private investors access to top-tier private market funds, has held the final closing of the Antwort Buyout Opportunities FF with €26 million in capital commitment from private investors. More than 60 investors from Luxembourg and internationally participated in the Fund.  The Fund’s aim is to get exposure to the private equity buyout segment in Europe and North America by investing in SwanCap’s multi-strategy fund “Swan V” as the underlying fund. SwanCap specialises in the private equity buyout segment and offers its predominantly institutional investors an “integrated investment strategy” by combining

StepStone Group, a global private markets investment firm, has held the final closing of StepStone Senior Corporate Lending II (SCL II), raising $1.3 billion of commitments, surpassing its target of $1 billion. Through SCL II, StepStone seeks to invest in post-Covid-19 vintage, senior secured, first-lien performing corporate loans. The portfolio will be diversified across geographies, managers, and single loan positions. Flexible allocations allow the Fund to allocate to GPs with the strongest pipelines. The Fund attracted a broad and diverse group of investors with support from existing investors and new investors to StepStone’s private debt platform. SCL II benefits from

Aquiline Capital Partners (Aquiline), a private investment firm based in New York and London with $8.7 billion in assets under management, has held the final closing of Aquiline Technology Growth Fund II (ATG II). The Fund closed with more than $365 million in total commitments, exceeding its target of $300 million and nearly doubling the $189 million in total commitments raised for Aquiline Technology Growth’s (ATG) first fund. Aquiline has raised the Fund from new and existing investors around the world and plans to continue ATG’s strategy of partnering with innovative early- and growth-stage technology companies across fintech, insuretech and

Capital Dynamics, an independent global private asset management firm, has held the final close of Capital Dynamics Future Essentials II (Future Essentials II) with EUR300 million in commitments. The fund is managed by a multinational investment team in North America, Europe and Asia and invests in high quality, limited access private equity primary funds, particularly mid-market buyout and growth capital funds, with additional allocation to co-investments and secondary transactions. This second-time fund significantly surpassed the size of its predecessor fund, which closed in January 2019.     Future Essentials II has already made substantial commitments through its access to propriety

Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm), has invetsted in AMF-regulated investment company AdBio partners’ second fund – AFB Fund II. Inserm Transfert joins the international limited partners who have invested in AdBio partners’ second fund. The initial closing announced in September 2021 reached €86 million ($102M). Among these other investors are the European Investment Fund (EIF), the French Seed Fund 2 (FNA 2), managed by Bpifrance on behalf of the French State as part of the future investments program, Boehringer Ingelheim Venture Fund, Pierre Fabre, various family offices and the management

Catalio Capital Management (Catalio), a multi-strategy life sciences investment firm, has closed its third venture fund, Catalio Nexus Fund III (Fund III), with more than $381 million in total capital commitments, exceeding its original $300 million dollar target.

SwanCap has held the final close of its latest private equity opportunities Fund (Swan V), which was oversubscribed with aggregated commitments in excess of €400 million. The Fund received strong support from a large number of existing investors as well as a wide range of new investors internationally. The LP base of Swan V includes many institutional investors, public and corporate pension funds, insurance companies, endowments, foundations as well as HNWs and large family offices.   Swan V continues the Firm´s proven investment strategy and provides diversified exposure to best-in-class private equity in the European and North American Midmarket via